The prevalence of anxiety syndrome in people with chronic non-communicable diseases in real clinical practice
N. Yu. Shimokhina,
Zh. R. Baranovich,
A. S. Yunevich,
A. A. Savchenko,
O. V. Zimnitskaya,
M. M. Petrova https://doi.org/10.21886/2712-8156-2023-4-2-101-108
Abstract
Objective: to study of the features of the spread of anxiety syndrome in patients with chronic non-communicable diseases (CNCD) in outpatient practice. Materials and methods: the study included persons of both sexes over 18 years of age who visited outpatient facilities in a large industrial center of Eastern Siberia in the summer of 2022. Diagnosis of chronic NCDs was established according to modern clinical guidelines. The examined were divided into two groups. The first group included persons without NCDs, the second group included patients with concomitant NCDs. The psycho-emotional state was assessed using the Spielberger-Khanin test with separate determination of the levels of personal and situational anxiety. Statistical data analysis was carried out using the Statistica 12.0 software package (StatSoft Inc., USA). Results: the level of situational anxiety in patients with chronic NCDs was statistically significantly higher compared to individuals without concomitant somatic pathology. In patients with chronic NCD, compared with individuals without them, a significant increase in the median scores for the level of low and moderately expressed personal anxiety and for the level of moderate and high situational anxiety was revealed. In the group of patients with CND, a high level of personal and situational anxiety was significantly more often observed in comparison with persons without CND. Conclusion: the prevalence of anxiety syndrome, especially situational anxiety in patients with chronic NCD in the outpatient network is quite high and reaches 93%, which requires a solution to the issue of practical psychiatric care for these patients.
About the Authors
N. Yu. Shimokhina
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Natalya Y. Shimokhina - Dr. Sci (Med.), Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University.
Krasnoyarsk
Zh. R. Baranovich
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Zhanna R. Baranovich.
Krasnoyarsk
A. S. Yunevich
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Anastasia S. Yunevich.
Krasnoyarsk
A. A. Savchenko
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Andrei A. Savchenko - Dr. Sci (Med.), Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University.
Krasnoyarsk
O. V. Zimnitskaya
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Olga V. Zimnitskaya - Cand. Sci. (Med.), Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University.
Krasnoyarsk
M. M. Petrova
Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Marina M. Petrova - Dr. Sci (Med.), Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University.
Krasnoyarsk
References
1. Charlson F, van Ommeren M, Flaxman A, Cornett J, Whiteford H, Saxena S. New WHO prevalence estimates of mental disorders in conflict settings: a systematic review and meta-analysis. Lancet. 2019;394(10194):240-248. doi: 10.1016/S0140-6736(19)30934-1.
2. Liu X, Cao H, Zhu H, Zhang H, Niu K, Tang N, et al. Association of chronic diseases with depression, anxiety and stress in Chinese general population: The CHCN-BTH cohort study. J Affect Disord. 2021;282:1278-1287. doi: 10.1016/j.jad.2021.01.040.
3. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7.
4. Arokiasamy P, Uttamacharya, Kowal P, Capistrant BD, Gildner TE, Thiele E, et al. Chronic Noncommunicable Diseases in 6 Low- and Middle-Income Countries: Findings From Wave 1 of the World Health Organization’s Study on Global Ageing and Adult Health (SAGE). Am J Epidemiol. 2017;185(6):414-428. doi: 10.1093/aje/kww125.
5. Hüfner K, Fuchs D, Blauth M, Sperner-Unterweger B. How acute and chronic physical disease may influence mental health - An Analysis of neurotransmitter precursor amino acid levels. Psychoneuroendocrinology. 2019;106:95-101. doi: 10.1016/j.psyneuen.2019.03.028.
6. Zhu J, Fang F, Sjölander A, Fall K, Adami HO, Valdimarsdóttir U. First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study. Ann Oncol. 2017;28(8):1964-1969. doi: 10.1093/annonc/mdx265.
7. Huang Y, Wang Y, Wang H, Liu Z, Yu X, Yan J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211-224. doi: 10.1016/S2215-0366(18)30511-X.
8. Silverman AL, Herzog AA, Silverman DI. Hearts and Minds: Stress, Anxiety, and Depression: Unsung Risk Factors for Cardiovascular Disease. Cardiol Rev. 2019;27(4):202-207. doi: 10.1097/CRD.0000000000000228.
9. Serpytis P, Navickas P, Lukaviciute L, Navickas A, Aranauskas R, Serpytis R, et al. Gender-Based Differences in Anxiety and Depression Following Acute Myocardial Infarction. Arq Bras Cardiol. 2018;111(5):676-683. doi: 10.5935/abc.20180161.
10. Zhang Y, Chen Y, Ma L. Depression and cardiovascular disease in elderly: Current understanding. J Clin Neurosci. 2018;47:1-5. doi: 10.1016/j.jocn.2017.09.022.
11. Hamam MS, Kunjummen E, Hussain MS, Nasereldin M, Bennett S, Miller J. Anxiety, Depression, and Pain: Considerations in the Treatment of Patients with Uncontrolled Hypertension. Curr Hypertens Rep. 2020;22(12):106. doi: 10.1007/s11906-020-01117-2.
12. Johnson HM. Anxiety and Hypertension: Is There a Link? A Literature Review of the Comorbidity Relationship Between Anxiety and Hypertension. Curr Hypertens Rep. 2019;21(9):66. doi: 10.1007/s11906-019-0972-5.
13. Volpato E, Toniolo S, Pagnini F, Banfi P. The Relationship Between Anxiety, Depression and Treatment Adherence in Chronic Obstructive Pulmonary Disease: A Systematic Review. Int J Chron Obstruct Pulmon Dis. 2021;16:2001-2021. doi: 10.2147/COPD.S313841.
14. Bisgaard TH, Allin KH, Keefer L, Ananthakrishnan AN, Jess T. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment. Nat Rev Gastroenterol Hepatol. 2022;19(11):717-726. doi: 10.1038/s41575-022-00634-6.
15. Benmaamar S, Lazar N, El Harch I, Maiouak M, Qarmiche N, Otmani N, et al. Depression and anxiety in patients with diabetes in a Moroccan region. Encephale. 2022;48(6):601-606. doi: 10.1016/j.encep.2021.06.014.
16. Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: A systematic review and meta-analysis. J Affect Disord. 2017;221:36-46. doi: 10.1016/j.jad.2017.06.009.
17. Smith L, Shin JI, Jacob L, Schuch F, Pizzol D, López Sánchez GF, et al. Physical multimorbidity predicts the onset and persistence of anxiety: A prospective analysis of the Irish Longitudinal Study on Ageing. J Affect Disord. 2022;309:71-76. doi: 10.1016/j.jad.2022.04.022.
18. Armbrecht E, Shah R, Poorman GW, Luo L, Stephens JM, Li B, et al. Economic and Humanistic Burden Associated with Depression and Anxiety Among Adults with Non-Communicable Chronic Diseases (NCCDs) in the United States. J Multidiscip Healthc. 2021;14:887-896. doi: 10.2147/JMDH.S280200.
19. Pierobon A, Ranzini L, Torlaschi V, Sini Bottelli E, Giardini A, Bruschi C, Maestri R, et al. Screening for neuropsychological impairment in COPD patients undergoing rehabilitation. PLoS One. 2018;13(8):e0199736. doi: 10.1371/journal.pone.0199736.
20. Shimokhina NY, Savchenko AA, Petrova MM. Peculiarities of Platelet Metabolism in Patients with Acute Coronary Syndrome with Anxiety-Depressive Disorders and Informativity of Enzymes in the Forecast of Development of Cardiovascular Complications. Pharmaceuticals (Basel). 2020;13(8):169. doi: 10.3390/ph13080169.
21. Драпкина О.М., Шепель Р.Н., Кабурова А.Н. Оценка субъективной ситуационной и личностной тревожности у лиц с избыточной массой тела. Неотложная кардиология и кардиоваскулярные риски, 2017, Т. 1, № 1, С. 83-88. eLIBRARY ID: 32522367.
22. Uphoff EP, Newbould L, Walker I, Ashraf N, Chaturvedi S, Kandasamy A, et al.; NIHR Global Health Research Group – IMPACT. A systematic review and meta-analysis of the prevalence of common mental disorders in people with non-communicable diseases in Bangladesh, India, and Pakistan. J Glob Health. 2019;9(2):020417. doi: 10.7189/jogh.09.020417.
23. Гацких ИВ, Окладникова ЕВ, Шалда ТП, Петрова ММ, Наркевич АН. Связь тревожно-депрессивных расстройств с когнитивными нарушениями у пациентов с сахарным диабетом. Сибирское медицинское обозрение. 2018;(2): 94-99. doi: 10.20333/2500136-2018-2-94-99.
24. Песковец РД, Штарик СЮ, Евсюков АА. Распространенность тревожных расстройств в общемедицинской сети и их связь с сердечно-сосудистыми заболеваниями. Сибирское медицинское обозрение. 2019;(6):73-79. doi: 10.20333/2500136-2019-6-73-79.
Review
For citations:
Shimokhina N.Yu., Baranovich Zh.R., Yunevich A.S., Savchenko A.A., Zimnitskaya O.V., Petrova M.M. The prevalence of anxiety syndrome in people with chronic non-communicable diseases in real clinical practice. South Russian Journal of Therapeutic Practice. 2023;4(2):101-108. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-2-101-108
Views:
977
Email this article 